Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
68.41 (1y: +49%)
Market Cap 2.38 B P/E(ttm) 28.80
Enterprise Value 2.62 B P/B 3.20
WST- NYSE (USA)
West Pharmaceutical Services, Inc.
  • Currently 2.5/5
Business Predictability Rank: 2.5-Star
Back Testing Results:
Average gain of all 2.5-Star stocks: 7.3% per year.
% of Stocks that are in still loss if held for 10yrs: 18%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$68.41
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.424
WST's Cash to Debt is ranked lower than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. WST: 0.424 )
WST' s 10-Year Cash to Debt Range
Min: 0.17   Max: 0.43
Current: 0.42
0.17
0.43
Equity to Asset 0.362
WST's Equity to Asset is ranked lower than
62% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. WST: 0.362 )
WST' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.39
Current: 0.36
0.21
0.39
Interest Coverage 9.1
WST's Interest Coverage is ranked lower than
68% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. WST: 9.1 )
WST' s 10-Year Interest Coverage Range
Min: 3   Max: 11
Current: 9.1
3
11
F-Score: 6
Z-Score: 3.66
M-Score: -2.84
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 10.70
WST's Operating margin (%) is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. WST: 10.70 )
WST' s 10-Year Operating margin (%) Range
Min: 6.4   Max: 14.2
Current: 10.7
6.4
14.2
Net-margin (%) 6.4
WST's Net-margin (%) is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. WST: 6.4 )
WST' s 10-Year Net-margin (%) Range
Min: -1.3   Max: 8.2
Current: 6.4
-1.3
8.2
ROE (%) 11.1
WST's ROE (%) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. WST: 11.1 )
WST' s 10-Year ROE (%) Range
Min: -2.9   Max: 17.7
Current: 11.1
-2.9
17.7
ROA (%) 5.2
WST's ROA (%) is ranked higher than
57% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. WST: 5.2 )
WST' s 10-Year ROA (%) Range
Min: -1   Max: 7.4
Current: 5.2
-1
7.4
ROC (Joel Greenblatt) (%) 16.40
WST's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. WST: 16.40 )
WST' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 9.6   Max: 22.7
Current: 16.4
9.6
22.7
Revenue Growth (%) 5
WST's Revenue Growth (%) is ranked higher than
57% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. WST: 5 )
WST' s 10-Year Revenue Growth (%) Range
Min: -1.7   Max: 12.7
Current: 5
-1.7
12.7
EBITDA Growth (%) 6.7
WST's EBITDA Growth (%) is ranked higher than
68% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. WST: 6.7 )
WST' s 10-Year EBITDA Growth (%) Range
Min: -11.6   Max: 15.5
Current: 6.7
-11.6
15.5
EPS Growth (%) 2.1
WST's EPS Growth (%) is ranked higher than
68% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.15 vs. WST: 2.1 )
WST' s 10-Year EPS Growth (%) Range
Min: -16   Max: 111.2
Current: 2.1
-16
111.2
ยป WST's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

WST Guru Trades in Q2 2012

Joel Greenblatt 25,159 sh (New)
Steven Cohen 8,808 sh (New)
Paul Tudor Jones 12,100 sh (New)
Ken Fisher 125,250 sh (+18.33%)
Jim Simons Sold Out
Ruane Cunniff 560,768 sh (-12.13%)
» More
Q3 2012

WST Guru Trades in Q3 2012

Ken Fisher 277,975 sh (+121.94%)
Joel Greenblatt 38,873 sh (+54.51%)
Ruane Cunniff 559,611 sh (-0.21%)
Steven Cohen 5,634 sh (-36.04%)
Paul Tudor Jones 7,500 sh (-38.02%)
» More
Q4 2012

WST Guru Trades in Q4 2012

Steven Cohen 15,301 sh (+171.58%)
Ken Fisher 634,322 sh (+128.19%)
Joel Greenblatt Sold Out
Ruane Cunniff 556,997 sh (-0.47%)
Paul Tudor Jones 5,600 sh (-25.33%)
» More
Q1 2013

WST Guru Trades in Q1 2013

Jim Simons 154,700 sh (New)
Steven Cohen 72,686 sh (+375.04%)
Paul Tudor Jones 11,800 sh (+110.71%)
Ken Fisher 639,039 sh (+0.74%)
Ruane Cunniff 560,432 sh (+0.62%)
» More
» Details

Insider Trades

Latest Guru Trades with WST

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Sold Out 0.14%$51.05 - $55.73 $ 68.4127%0
Joel Greenblatt 2012-09-30 Add 54.51%0.05%$47.13 - $53.46 $ 68.4138%38873
Joel Greenblatt 2012-06-30 New Buy0.09%$39.5 - $50.23 $ 68.4151%25159
Joel Greenblatt 2012-03-31 Sold Out 0.07%$37.79 - $42.8 $ 68.4178%0
Ruane Cunniff 2011-12-31 Add 134.01%0.12%$35.6 - $41.14 $ 68.4181%637162
Joel Greenblatt 2011-12-31 New Buy0.07%$35.6 - $41.14 $ 68.4181%14667
Ruane Cunniff 2011-09-30 Add 286.3%0.08%$36.91 - $46.45 $ 68.4165%272285
Joel Greenblatt 2011-06-30 Sold Out 0.18%$42.38 - $47.44 $ 68.4152%0
Joel Greenblatt 2011-03-31 Add 145.88%0.11%$38.81 - $44.52 $ 68.4166%13152
Joel Greenblatt 2010-12-31 New Buy0.07%$33.48 - $42.21 $ 68.4179%5349
Ruane Cunniff 2010-12-31 Add 43.75%0.01%$33.48 - $42.21 $ 68.4179%68995
Ruane Cunniff 2010-09-30 New Buy0.02%$33.04 - $36.97 $ 68.4197%47995
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 28.80
WST's P/E(ttm) is ranked higher than
63% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.40 vs. WST: 28.80 )
WST' s 10-Year P/E(ttm) Range
Min: 10.1   Max: 2765
Current: 28.8
10.1
2765
P/B 3.20
WST's P/B is ranked lower than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. WST: 3.20 )
WST' s 10-Year P/B Range
Min: 1.29   Max: 4.2
Current: 3.2
1.29
4.2
P/S 1.88
WST's P/S is ranked higher than
62% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. WST: 1.88 )
WST' s 10-Year P/S Range
Min: 0.62   Max: 1.91
Current: 1.88
0.62
1.91
PFCF 77.60
WST's PFCF is ranked lower than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.35 vs. WST: 77.60 )
WST' s 10-Year PFCF Range
Min: 10.71   Max: 1033.2
Current: 77.6
10.71
1033.2
EV-to-EBIT 18.9
WST's EV-to-EBIT is ranked higher than
78% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.12 vs. WST: 18.9 )
WST' s 10-Year EV-to-EBIT Range
Min: 6.9   Max: 25.8
Current: 18.9
6.9
25.8
PEG 7.3
WST's PEG is ranked lower than
70% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. WST: 7.3 )
WST' s 10-Year PEG Range
Min: 0.72   Max: 184
Current: 7.3
0.72
184
Shiller P/E 29.6
WST's Shiller P/E is ranked higher than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.85 vs. WST: 29.6 )
WST' s 10-Year Shiller P/E Range
Min: 16.04   Max: 61.11
Current: 29.6
16.04
61.11

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 1.10
WST's Dividend Yield is ranked higher than
76% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. WST: 1.10 )
WST' s 10-Year Dividend Yield Range
Min: 0.96   Max: 4.29
Current: 1.1
0.96
4.29
Dividend Payout 0.3149
WST's Dividend Payout is ranked higher than
84% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.53 vs. WST: 0.3149 )
WST' s 10-Year Dividend Payout Range
Min: 0.24   Max: 6.21
Current: 0.31
0.24
6.21
Dividend growth (3y) 4.6
WST's Dividend growth (3y) is ranked higher than
93% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. WST: 4.6 )
WST' s 10-Year Dividend growth (3y) Range
Min: 3.9   Max: 6.1
Current: 4.6
3.9
6.1
Yield on cost (5-Year) 1.50
WST's Yield on cost (5-Year) is ranked higher than
80% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. WST: 1.50 )
WST' s 10-Year Yield on cost (5-Year) Range
Min: 1.31   Max: 5.85
Current: 1.5
1.31
5.85
Share Buyback Rate 0.3
WST's Share Buyback Rate is ranked higher than
70% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. WST: 0.3 )
WST' s 10-Year Share Buyback Rate Range
Min: 1   Max: -4.1
Current: 0.3

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 12.1
WST's Price/Net Current Asset Value is ranked higher than
53% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. WST: 12.1 )
WST' s 10-Year Price/Net Current Asset Value Range
Min: 5   Max: 14.6
Current: 12.1
5
14.6
Price/Tangible Book 4.2
WST's Price/Tangible Book is ranked higher than
64% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. WST: 4.2 )
WST' s 10-Year Price/Tangible Book Range
Min: 2.3   Max: 7
Current: 4.2
2.3
7
Price/DCF (Projected) 2.7
WST's Price/DCF (Projected) is ranked higher than
94% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. WST: 2.7 )
WST' s 10-Year Price/DCF (Projected) Range
Min: 1.7   Max: 2.9
Current: 2.7
1.7
2.9
Price/Median PS Value 1.5
WST's Price/Median PS Value is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.90 vs. WST: 1.5 )
WST' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.5
Current: 1.5
0.7
1.5
Price/Peter Lynch Fair Value 5.5
WST's Price/Peter Lynch Fair Value is ranked lower than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. WST: 5.5 )
WST' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1   Max: 3.3
Current: 5.5
1
3.3
Price/Graham Number 2.4
WST's Price/Graham Number is ranked higher than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. WST: 2.4 )
WST' s 10-Year Price/Graham Number Range
Min: 1.3   Max: 4.8
Current: 2.4
1.3
4.8
Earnings Yield (Greenblatt) 5.30
WST's Earnings Yield (Greenblatt) is ranked lower than
80% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. WST: 5.30 )
WST' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 14.5
Current: 5.3
3.9
14.5
Forward Rate of Return (Yacktman) 6.02
WST's Forward Rate of Return (Yacktman) is ranked higher than
64% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.11 vs. WST: 6.02 )
WST' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13   Max: 24.7
Current: 6.02
-13
24.7

Business Description

West Pharmaceutical Services, Inc. was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923. It is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare and consumer products industries. Majority of its business is conducted in healthcare markets. Its reportable segments are Packaging Systems and Delivery Systems. Packaging Systems develops, manufactures and sells primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Delivery Systems develops, manufactures and sells safety and administration systems, multi-component systems for drug administration, and a variety of custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. In addition, Delivery Systems is responsible for the continued development and commercialization of the Company's line of proprietary, multi-component systems for injectable drug administration and other healthcare applications. Packaging Systems has three operating segments: the Americas, Europe and Asia Pacific. The Company competes with several companies across its major product lines. Competition is based mainly on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost control programs across their entire operations. The design, development, manufacturing, marketing and labeling of certain of the Company's products and its customers' products that incorporate its products are subject to regulation by governmental authorities in the United States, Europe and other countries, including the FDA and the European Medicines Agency.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:BAX, COV, TMO, COO, ISRG
Traded in other countries:WPS.Germany
ยป More Articles for WST

Headlines

Articles On GuruFocus.com
12 Healthcare Dividend Stocks With Highest Short Float Ratio Jun 02 2012 
The Best Dividends on April 16, 2012 Apr 13 2012 
20 Dividend Achiever with Highest Earnings Forecasts Nov 29 2011 
Sequoia Fund Managers Buys Waters Corp., Berkshire Hathaway, Chesapeake Energy, Sells McGrawhill, W. Nov 16 2011 
7 Stocks Increasing the Compounding Power of Dividends Oct 17 2011 
West Pharmaceutical Services Inc. Reports Operating Results (10-K) Feb 28 2011 
West Pharmaceutical Services Inc. (WST) COO & President Steven A Ellers sells 10,000 Shares Feb 24 2010 
West Pharmaceutical Services Inc. Reports Operating Results (10-Q) Nov 04 2009 
West Pharmaceutical Services Inc. (WST) COO & President Steven A Ellers sells 10,000 Shares Sep 01 2009 
West Pharmaceutical Services Inc. (WST) COO & President Steven A Ellers sells 10,000 Shares Aug 25 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial